Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
2.360
+0.030 (1.29%)
At close: Jun 18, 2025, 4:00 PM
2.400
+0.040 (1.68%)
After-hours: Jun 18, 2025, 7:51 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $366.08 million as of June 18, 2025. Its market cap has decreased by -58.29% in one year.
Market Cap
366.08M
Enterprise Value
385.75M
1-Year Change
-58.29%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $366.08M, an increase of 194.50%. That is a compound annual growth rate of 26.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 366.08M | -43.66% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 705.63B |
| Johnson & Johnson | 363.39B |
| Novo Nordisk | 334.60B |
| AbbVie | 328.80B |
| UnitedHealth Group | 281.90B |
| Abbott Laboratories | 231.22B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |